• 1
    Sakaguchi, S., Yamaguchi, T., Nomura, T. and Ono, M., Regulatory T cells and immune tolerance. Cell 2008. 133: 775787.
  • 2
    Schubert, L. A., Jeffery, E., Zhang, Y., Ramsdell, F. and Ziegler, S. F., Scurfin (FOXP3) acts as a repressor of transcription and regulates T cell activation. J. Biol. Chem. 2001. 276: 3767237679.
  • 3
    Bluestone, J. A. and Abbas, A. K., Natural versus adaptive regulatory T cells. Nat. Rev. Immunol. 2003. 3: 253257.
  • 4
    Horwitz, D. A., Zheng, S. G., Gray, J. D., Wang, J. H., Ohtsuka, K. and Yamagiwa, S., Regulatory T cells generated ex vivo as an approach for the therapy of autoimmune disease. Semin. Immunol. 2004. 16: 135143.
  • 5
    Horwitz, D. A., Zheng, S. G. and Gray, J. D., Natural and TGF-beta-induced Foxp3(+)CD4(+) CD25(+) regulatory T cells are not mirror images of each other. Trends Immunol. 2008. 29: 429435.
  • 6
    Zheng, S. G., Gray, J. D., Ohtsuka, K., Yamagiwa, S. and Horwitz, D. A., Generation ex vivo of TGF-beta-producing regulatory T cells from CD4+CD25 precursors. J. Immunol. 2002. 169: 41834189.
  • 7
    Chen, W., Jin, W., Hardegen, N., Lei, K. J., Li, L., Marinos, N., McGrady, G. and Wahl, S. M., Conversion of peripheral CD4+CD25 naive T cells to CD4+CD25+ regulatory T cells by TGF-beta induction of transcription factor Foxp3. J. Exp. Med. 2003. 198: 18751886.
  • 8
    Zheng, S. G., Wang, J. H., Gray, J. D., Soucier, H. and Horwitz, D. A., Natural and induced CD4+CD25+ cells educate CD4+CD25 cells to develop suppressive activity: the role of IL-2, TGF-beta, and IL-10. J. Immunol. 2004. 172: 52135221.
  • 9
    Fantini, M. C., Becker, C., Monteleone, G., Pallone, F., Galle, P. R. and Neurath, M. F., Cutting edge: TGF-beta induces a regulatory phenotype in CD4+CD25 T cells through Foxp3 induction and down-regulation of Smad7. J. Immunol. 2004. 172: 51495153.
  • 10
    Marie, J. C., Letterio, J. J., Gavin, M. and Rudensky, A. Y., TGF-beta1 maintains suppressor function and Foxp3 expression in CD4+CD25+ regulatory T cells. J. Exp. Med. 2005. 201: 10611067.
  • 11
    Zheng, S. G., Wang, J., Wang, P., Gray, J. D. and Horwitz, D. A., IL-2 is essential for TGF-beta to convert naive CD4+CD25 cells to CD25+Foxp3+ regulatory T cells and for expansion of these cells. J. Immunol. 2007. 178: 20182027.
  • 12
    Piccirillo, C. A., Letterio, J. J., Thornton, A. M., McHugh, R. S., Mamura, M., Mizuhara, H. and Shevach, E. M., CD4(+)CD25(+) regulatory T cells can mediate suppressor function in the absence of transforming growth factor beta1 production and responsiveness. J. Exp. Med. 2002. 196: 237246.
  • 13
    Li, M. O., Sanjabi, S. and Flavell, R. A., Transforming growth factor-beta controls development, homeostasis, and tolerance of T cells by regulatory T cell-dependent and -independent mechanisms. Immunity 2006. 25: 455471.
  • 14
    von Boehmer, H. and Nolting, J., What turns on Foxp3? Nat. Immunol. 2008. 9: 121122.
  • 15
    Sporn, M. B. and Roberts, A. B., The transforming growth factor bs, in Sporn, M. B. and Roberts, A. B. (Eds.), Peptide Growth Factors and Their Receptor: Handbook of Experimental Pharmacology, Springer-Verlag, Heidelberg 1991. pp. 419472.
  • 16
    Hogan, B. L., Bone morphogenetic proteins: multifunctional regulators of vertebrate development. Genes. Dev. 1996. 10: 15801594.
  • 17
    Bleul, C. C. and Boehm, T., BMP signaling is required for normal thymus development. J. Immunol. 2005. 175: 52135221.
  • 18
    Bhatia, M., Bonnet, D., Wu, D., Murdoch, B., Wrana, J., Gallacher, L. and Dick, J. E., Bone morphogenetic proteins regulate the developmental program of human hematopoietic stem cells. J. Exp. Med. 1999. 189: 11391148.
  • 19
    Shi, Y. and Massague, J., Mechanisms of TGF-beta signaling from cell membrane to the nucleus. Cell 2003. 113: 685700.
  • 20
    Massague, J., TGF-beta signal transduction. Annu. Rev. Biochem. 1998. 67: 753791.
  • 21
    Attisano, L. and Wrana, J. L., Smads as transcriptional co-modulators. Curr. Opin. Cell Biol. 2000. 12: 235243.
  • 22
    Licona-Limón, P. and Soldevila, G., The role of TGF-beta superfamily during T cell development: new insights. Immunol. Lett. 2007. 109: 112.
  • 23
    Sivertsen, E. A., Huse, K., Hystad, M. E., Kersten, C., Smeland, E. B. and Myklebust, J. H., Inhibitory effects and target genes of bone morphogenetic protein 6 in Jurkat Tag cells. Eur. J. Immunol. 2007. 37: 29372948.
  • 24
    Winnier, G., Blessing, M., Labosky, P. A. and Hogan, B. L., Bone morphogenetic protein-4 is required for mesoderm formation and patterning in the mouse. Genes Dev. 1995. 9: 2105.
  • 25
    Chang, H., Huylebroeck, D., Verschueren, K., Guo, Q., Matzuk, M. M. and Zwijsen, A., Smad5 knockout mice die at mid-gestation due to multiple embryonic and extraembryonic defects. Development 1999. 126: 16311642.
  • 26
    Rifas, L., The role of noggin in human mesenchymal stem cell differentiation. J. Cell. Biochem. 2007. 100: 824834.
  • 27
    Tao, R., de Zoeten, E. F., Ozkaynak, E., Chen, C., Wang, L., Porrett, P. M., Li, B. et al., Deacetylase inhibition promotes the generation and function of regulatory T cells. Nat. Med. 2007. 13:12991307.
  • 28
    Reilly, C. M., Thomas, M., Gogal, R., Jr., Olgun, S., Santo, A., Sodhi, R., Samy, E. T. et al., The histone deacetylase inhibitor trichostatin A upregulates regulatory T cells and modulates autoimmunity in NZB/W F1 mice. J. Autoimmun. 2008. 2:123130.
  • 29
    Huber, S., Schrader, J., Fritz, G., Presser, K., Schmitt, S., Waisman, A., Lüth, S. et al., P38 MAP kinase signaling is required for the conversion of CD4+CD25 T cells into iTreg. PLoS ONE 2008. 3: e3302.
  • 30
    Saraiva, M., Christensen, J. R., Veldhoen, M., Murphy, T. L., Murphy, K. M. and O'Garra, A., Interleukin-10 Production by Th1 Cells Requires Interleukin-12-Induced STAT4 Transcription Factor and ERK MAP Kinase Activation by High Antigen Dose. Immunity 2009. 31:209219.
  • 31
    Zheng, S. G., Wang, J. H., Koss, M. N., Quismorio, F., Jr., Gray, J. D. and Horwitz, D. A., CD4+ and CD8+ regulatory T cells generated ex vivo with IL-2 and TGF-beta suppress a stimulatory graft-versus-host disease with a lupus-like syndrome. J. Immunol. 2004. 172: 15311539.
  • 32
    Zheng, S. G., Meng, L., Wang, J. H., Watanabe, M., Barr, M. L., Cramer, D. V., Gray, J. D. and Horwitz, D. A., Transfer of regulatory T cells generated ex vivo modifies graft rejection through induction of tolerogenic CD4+CD25+ cells in the recipient. Int. Immunol. 2006.18: 279289.
  • 33
    Walker, M. R., Carson, B. D., Nepom, G. T., Ziegler, S. F. and Buckner, J. H., De novo generation of antigen-specific CD4+CD25+ regulatory T cells from human CD4+CD25 cells. Proc. Natl. Acad. Sci. USA 2005. 102: 41034108.
  • 34
    Derynck, R. and Zhang, Y. E., Smad-dependent and Smad-independent pathways in TGF-beta family signalling. Nature 2003.425: 577584.
  • 35
    Zheng, S. G., Wang, J. H., Stohl, W., Kim, K. S., Gray, J. D. and Horwitz, D. A., TGF-beta requires CTLA-4 early after T cell activation to induce FoxP3 and generate adaptive CD4+CD25+ regulatory cells. J. Immunol. 2006. 176:33213329.
  • 36
    Huber, S., Stahl, F. R., Schrader, J., Lüth, S., Presser, K., Carambia, A., Flavell, R. A. et al., Activin a promotes the TGF-beta-induced conversion of CD4+CD25 T cells into Foxp3+ induced regulatory T cells. J. Immunol. 2009. 182:46334640.
  • 37
    Utsugisawa, T., Moody, J. L., Aspling, M., Nilsson, E., Carlsson, L. and Karlsson, S., A road map toward defining the role of Smad signaling in hematopoietic stem cells. Stem Cells 2006. 24: 11281136.
  • 38
    Chytil, A., Magnuson, M. A., Wright, C. V. and Moses, H. L., Conditional inactivation of the TGF-beta type II receptor using Cre:Lox. Genesis 2002. 32: 7375.
  • 39
    Shi, W., Chen, H., Sun, J., Buckley, S., Zhao, J., Anderson, K. D., Williams, R. G. and Warburton,D., TACE is required for fetal murine cardiac development and modeling. Dev. Biol. 2003. 261:371380.